Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Request for Pharmacist

 
Establishing/Expanding MediTrack system for pharmaceutical products
Terms of Reference: Pharmacist
National E-health Program
 
1- Background

For several years, the Ministry of Public Health (MoPH) has been working on pharmaceutical sector reform, which has positively impacted the quality, safety, and efficacy of pharmaceutical products, as well as Lebanon's overall health status.

In 2018, the MoPH began the process of implementing the National Barcode System in Lebanon by requesting that all registered pharmaceutical importers and local manufacturers who intend to import or produce pharmaceutical products use the 2D Matrix Barcode, as per the standards of the "Global Standards One" GS1, on the outer pack of all registered/under-registration pharmaceutical products. The "MediTrack" pharmaceutical traceability information system was created to connect all stakeholders in the supply chain in a single network and allow them to share information.

Since 2020, the "MediTrack" system has been implemented in all drugstores (around 200) to track imported medications all the way back to the supplier's purchase and distribution.

In 2022, due to the limited budget allocated by the Lebanese central bank for total subsidization of catastrophic illness medications, there is an urgent need to track the dispensing of cancer medications up to the patient level in both the public and private sectors.

In September 2022, a pilot phase was launched to connect hospitals and community pharmacies with WHO support to test the system, evaluate its feasibility, time, and cost, and identify gaps to improve system performance prior to a full-scale project implementation.

The first phase of the project was completed successfully by developing the MediTrack system in accordance with GS1 requirements, testing the software program, and conducting a pilot run with the required stakeholders. MediTrack is now used by 60 hospitals and 180 pharmacies to dispense subsidized catastrophic illness medications to their patients. There are approximately 3800 remaining pharmacies, in addition to the remaining hospitals and PHC centers, that must be linked to MediTrack by 2023.

Following the successful implementation of the NBS at the MOPH with medicine importers and distributors, the MoPH eHealth department launched phase two of the NBS, with WHO support, to achieve the MediTrack goal of tracing all types of medicines all the way up to the patient level.

According to the decision, the inspection department was connected to MediTrack by January 2023, and inspectors began their official role on MediTrack. All imported medications added to MediTrack by importers remain pending until the inspector approves and the products are released to the market.

More than three thousand community pharmacies will be linked to Meditrack, and according to MOPH decree 988, all MOPH registered medications will be distributed to pharmacies through Meditrack beginning in January 2024.

2- Job Description

Under the direct supervision of the Head of the National E-health program (Ms. Lina Abou Mrad), the Pharmacist role is to ensure timely and accurate data related to pharmaceutical products on MoPH data platforms mainly the MediTrack system. The pharmacist will help in establishing rules and procedures for the data validation of pharmaceutical products information systems and will ensure data privacy across MoPH departments and external stakeholders. He/she will also support in the proper implementation at all Meditrack system stakeholders.

3- Job Type

Full Time

4- Work to be Performed.
 
Output 1: Timely and accurately update MediTrack database System through continuous follow-up with pharmacies and health facilities mainly the following tasks:
  • Input non registered medications or donations data into MediTrack.
  • Update the GTIN for the donations and non-registered medications.
  • Update reception data for all donations and non-registered medications on MediTrack (even if products don’t have a 2D barcode).
- Deliverable 1.1: Provide monthly updated number of registered pharmacies through Meditrack on respective database with exchange rates and checking on transactions performed.
- Deliverable 1.2: Provide weekly updated database of from active Meditrack implementers (pharmaceutical companies, manufacturers, importers, wholesalers/distributors)
o Provide monthly status towards reaching the planned targets (ex: number of pharmacies per region connected to the system).
 
Output 2: Conduct visits to Meditrack stakeholders with skills and knowledge to present and respond to inquiries from multiple Meditrack stakeholders.
- Deliverable 2.1: A weekly schedule of visits to community and hospital pharmacies
- Deliverable 2.2: Fill the standard questionnaire , with the ability to respond to inquiries on Meditrack implementation.
- Deliverable 2.3: Report on the status of the Meditrack implementation
 
Output 3: Provide and assist in the training on MediTrack to pharmaceutical companies, hospitals, pharmacies, and all stakeholders.
- Deliverable 3.1: training sessions recording.
- Deliverable 3.2: follow-up with trainees for Meditrack setup and implementation.
 
Output 4: Review pricing and repricing files submitted for local and imported products and calculate the authorized price according to pricing decisions.
- Deliverable 4.1: Review price revisions submitted (for price increase, price decrease, and objections) and provide the accepted authorized price.
- Deliverable 4.2: prepare the drugs pricing Index according to the foreign currency rates provided from BDL.
 
- Perform any other task requested from the Head of the National E-Health Program.
 
5- Specific requirements

Qualifications required: PharmD degree, Master of Science in Pharmacy, or any equivalent degree. Graduates with a bachelor’s degree are eligible if they demonstrate more years of experience.

Experience required:
Essential:Two years’ relevant work experience in pharmaceutical supply chain management. - Proven experience in public related settings. - Lebanese Nationality.
 
Skills / Technical skills and knowledge:
- Strong knowledge of the legal and regulatory frameworks of pharmaceuticals products in Lebanon.
- Proven record of conducting pharmaceutical provision, pharma, and health products management.
- Effective communication, interpersonal and organizational skills.
- General ability to report, draft ideas and concepts, clearly and concisely in written and oral form.
- General ability to research, analyze, evaluate, and synthesize qualitative and quantitative information.
- Computer Skills: Excellent knowledge of Microsoft Office including Word.

Language requirements:
English; Arabic; French (read, write, speak)

6- Place of assignment

Submit your cv to the Ministry of Public Health email address: info@moph.gov.lb 
    ...
    6
    ...
ATC Name B/G Ingredients Dosage Form Price
M01AB05 DICLO-DENK 50 G Diclofenac sodium - 50mg 50mg Tablet, enteric coated 893,655 L.L
M01AB05 DICLOGESIC G Diclofenac sodium - 50mg 50mg Tablet, enteric coated 205,608 L.L
M01AB55 DIFEN FLEX G Diclofenac sodium - 50mg, Pridinol mesylate - 4mg Tablet, film coated 575,165 L.L
M01AB05 DIVIDO 75MG B Diclofenac sodium - 75mg 75mg Capsule, dual release 502,597 L.L
M01AB55 DIOXAFLEX B12 G Diclofenac sodium - 75mg, Betamethasone (sodium phosphate) - 2mg, Hydroxocobalamin sulphate - 10mg Injectable solution 1,104,639 L.L
M01AB55 DIOXAFLEX B12 G Diclofenac sodium - 75mg, Betamethasone (sodium phosphate) - 2mg, Hydroxocobalamin sulphate - 10mg Injectable solution 620,855 L.L
M01AB55 DIFEN B12 G Diclofenac sodium - 75mg, Prednisolone sodium phosphate - 10.08mg, Hydroxocobalamin acetate - 10.44mg Injectable solution 978,317 L.L
M01AB55 DIFEN FLEX G Diclofenac sodium - 75mg, Pridinol mesylate - 2.2mg Injectable solution 1,131,515 L.L
M01AB05 DICLOCELL G Diclofenac sodium - 75mg/3ml 75mg/3ml Injectable solution 945,809 L.L
M01AB05 DICLO-DENK 75 INJECTION G Diclofenac sodium - 75mg/3ml 75mg/3ml Injectable solution 716,268 L.L
M01AB05 DOLONIL G Diclofenac sodium - 75mg/3ml 75mg/3ml Injectable solution 337,880 L.L
M01AB05 DOLONIL G Diclofenac sodium - 75mg/3ml 75mg/3ml Injectable solution 3,801,155 L.L
D11AX18 DILO G Diclofenac sodium - 8% 8% Spray 502,981 L.L
G03DB08 DIENOSIS G Dienogest - 2mg 2mg Tablet 2,822,069 L.L
C05AE03 DILTIGEL G Diltiazem HCl - 2% 2% Gel 632,950 L.L
C05CA03 DIOVENOR 600 B Diosmin - 600mg 600mg Tablet, film coated 1,089,856 L.L
C05CA03 DIOVENOR 600 B Diosmin - 600mg 600mg Tablet 544,256 L.L
D04AA32 DERMAMINE ITCH STOPPING G Diphenhydramine HCl - 1%, Zinc acetete - 0.1% Cream 560,382 L.L
R06AA02 DIPHENIST G Diphenhydramine HCl - 50mg/ml 50mg/ml Injectable solution 6,977,230 L.L
J07CA11 DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE B Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein - Injectable suspension 1,515,854 L.L
C01CA07 DOBUTAMINE PANPHARMA G Dobutamine (HCl) - 250mg/20ml 250mg/20ml Injectable concentrated solution 2,701,123 L.L
L01CD02 DOCETAXEL EBEWE G Docetaxel - 20mg/2ml 20mg/2ml Injectable solution 5,313,553 L.L
L01CD02 DOCETAXEL ACCORD G Docetaxel - 20mg/ml 20mg/1ml Injectable concentrate for solution 4,110,814 L.L
L01CD02 DOCETAXEL GP PHARM G Docetaxel - 40mg/ml 80mg/2ml Injectable concentrated solution+diluent 16,777,239 L.L
L01CD02 DOCETAXEL GP PHARM G Docetaxel - 40mg/ml 20mg/0.5ml Injectable concentrated solution+diluent 4,567,721 L.L
L01CD02 DOCETAXEL ACCORD G Docetaxel - 80mg/4ml 80mg/4ml Injectable concentrate for solution 15,099,641 L.L
L01CD02 DOCETAXEL SPC G Docetaxel - 80mg/4ml 80mg/4ml Injectable concentrate for solution 16,906,027 L.L
L01CD02 DOCETAXEL EBEWE G Docetaxel - 80mg/8ml 80mg/8ml Injectable solution 19,518,281 L.L
A03FA03 DOMPERIDONE BIOGARAN G Domperidone - 10mg 10mg Tablet, coated 116,914 L.L
A03FA03 DOMIDONE CHAPHA SUGAR FREE G Domperidone - 5mg/5ml 5mg/5ml Suspension 319,963 L.L
    ...
    6
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025